Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

CJC-1295 DAC 5mg + Ipamorelin 5mg Stack | PeptideDosages.com

CJC-1295 DAC (5 mg) + Ipamorelin (5 mg) Stack Dosage Protocol CJC-1295 DAC Dosage Chart CJC-1295 DAC is dosed at 1 mg–2 mg weekly via subcutaneous injection in educational protocols. A 5 mg reconstituted with bacteriostatic water yields about 2.5 mg/mL. This i

CJC-1295 DAC (5 mg) + Ipamorelin (5 mg) Stack Dosage Protocol

CJC-1295 DAC Dosage Chart

CJC-1295 DAC is dosed at 1 mg–2 mg weekly via subcutaneous injection in educational protocols. A 5 mg reconstituted with bacteriostatic water yields about 2.5 mg/mL. This information is for research and educational use only.

CJC-1295 DAC: Add 2.0 mL bacteriostatic water → 2.5 mg/mL; inject once weekly.

Ipamorelin: Add 3.0 mL bacteriostatic water → 1.67 mg/mL; inject once daily.

Easy measuring: CJC-1295 DAC: 1 unit = 25 mcg; Ipamorelin: 1 unit ≈ 16.7 mcg on U-100 syringes.

Storage: Lyophilized: ≤−15 °C (5 °F); reconstituted: 2–8 °C (35.6–46.4 °F); use within 3–4 weeks[5].

This stacked protocol combines CJC-1295 DAC, a long-acting GHRH analog with extended half-life via albumin binding[1], and Ipamorelin, a selective ghrelin-receptor agonist that triggers potent GH pulses with minimal ACTH/cortisol release[2]. Together, these peptides amplify endogenous growth hormone secretion and IGF-1 signaling through complementary mechanisms[3].

Related research: For distinct compound, component, or formulation evidence and safety context, read Ipamorelin Peptide: Benefits, Uses, Side Effects, Dosage, and Research and CJC-1295 DAC Peptide: Benefits, Uses, Side Effects, Dosage, and Research. These links are comparisons only; the compounds and formulations should not be treated as interchangeable.

CJC-1295 DAC (5 mg Vial) — Subcutaneous, Once Weekly

Reconstitution: 2.0 mL bacteriostatic water → 2.5 mg/mL (2500 mcg/mL) → 25 mcg per unit

Standard

1000 mcg (1.0 mg)

40 units (0.40 mL)

Once weekly

Aggressive

2000 mcg (2.0 mg)

80 units (0.80 mL)

Note: At 2.5 mg/mL, each 5 mg vial provides 2.5 standard doses (1 mg each) or 1.25 aggressive doses (2 mg each).

CJC-1295 DAC Reconstitution Steps

Draw 2.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming or direct stream onto powder.

Gently swirl/roll until fully dissolved (do not shake).

Label with date and refrigerate at 2–8 °C (35.6–46.4 °F).

Ipamorelin (5 mg Vial) — Subcutaneous, Once Daily

Reconstitution: 3.0 mL bacteriostatic water → 1.67 mg/mL (1666.7 mcg/mL) → 16.67 mcg per unit

Weeks 1–2 (Initiation)

100 mcg (0.1 mg)

6 units (0.06 mL)

Once daily

Weeks 3–4 (Titration)

150 mcg (0.15 mg)

9 units (0.09 mL)

Weeks 5+ (Maintenance)

200 mcg (0.2 mg)

12 units (0.12 mL)

Aggressive (Optional)

300 mcg (0.3 mg)

18 units (0.18 mL)

Once daily or split 2×/day

For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Ipamorelin Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake).

Combined Stack Schedule — Standard Approach

Weeks 1–2

1000 mcg (40 units) once weekly

100 mcg (6 units) once daily

Weeks 3–4

150 mcg (9 units) once daily

Weeks 5–12

200 mcg (12 units) once daily

Timing: CJC-1295 DAC is typically administered on a fixed day each week. Ipamorelin is commonly administered before bed to coincide with natural nocturnal GH pulses[4].

Supplies Needed

Plan based on an 8–16 week stacked protocol with standard dosing (CJC-1295 DAC 1 mg/week + Ipamorelin 200 mcg/day at maintenance).

CJC-1295 DAC Vials (5 mg each):

8 weeks (8 mg total) → 2 vials

12 weeks (12 mg total) → 3 vials

16 weeks (16 mg total) → 4 vials

Ipamorelin Vials (5 mg each):

8 weeks (56 days at ~200 mcg/day) → 3 vials

12 weeks (84 days) → 4 vials

16 weeks (112 days) → 5 vials

Insulin Syringes (U-100):

Per week: 1 (CJC) + 7 (Ipamorelin) = 8 syringes

8 weeks: 64 syringes

12 weeks: 96 syringes

16 weeks: 128 syringes

For Ipamorelin doses ≤10 units, 30- or 50-unit syringes improve accuracy.

Bacteriostatic Water (10 mL bottles):

8 weeks: CJC (2 × 2 mL = 4 mL) + Ipam (3 × 3 mL = 9 mL) = 13 mL → 2 × 10 mL bottles

12 weeks: CJC (3 × 2 mL = 6 mL) + Ipam (4 × 3 mL = 12 mL) = 18 mL → 2 × 10 mL bottles

16 weeks: CJC (4 × 2 mL = 8 mL) + Ipam (5 × 3 mL = 15 mL) = 23 mL → 3 × 10 mL bottles

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Why CJC-1295 DAC + Ipamorelin draws research interest

These are the directions researchers and the peptide community most often explore CJC-1295 DAC + Ipamorelin for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.